Member Info for Fruitsnveg

Apologies ProfSPD, I posted wrong link there - if you google sudden death footballers, you will find a similar list (where death was caused by undetected disease rather than collisions on the field etc)

ProfessorSPD,

Sudden death is not a new occurrence, it's been around since the dawn of man but certainly amongst top sporting athletes (and juniors) for decades. Below is a lengthy list from pre-vaccine days. You can't blame the vaccine for all those premature deaths. When you put the body through high-stress sports, that's when any undetected disease is likely going to come to the fore, not when you're resting in a bubble bath, so the fact that 4 were reported in a short timeframe, across a world population, fits with what seems to be undetected cardiac issues (or other serious but undetected medical issue):

https://en.wikipedia.org/wiki/List_of_association_footballers_who_died_while_playing

Goosebumps. Remembering hearing this on the day it came out.

Matterhorn,
Shantaram, I gave to a friend travelling to India but never read myself. Glad to hear it's a good read, I must dig out a copy.

So, 2 days ago Synairgen plc tweeted this:
"Synairgen is wishing you health and happiness this holiday season and throughout the New Year.
Happy Holidays!"

How very 'American'...... hmmmm?!

Merry Christmas. Raising a glass and wishing you all a joyous one.

I think your suggestion is a good one Brand - further studies would produce evidence that would give answers and allay fears/stop conspiracy theories, but most of all people deserve to know.
Growing up I remember a fair few cases of sudden death amongst youth players (and I don't think it's changed that much as there are still cases). Undiagnosed hearth conditions I believe they were attributed it to, always in healthy, sporty young individuals who had no seeming underlying conditions. Perhaps more research was needed then, as now, to get to the root of it.

Docdaneeka,
No one is arguing the toss about how severe the new variant is on an individual basis, real world SA data so far indicates milder symptoms. But you conflate individual severity risk with overall hospitalization risk across a (different) population of millions - 2 very different things, as SAGE, Whitty, and ICL keep trying to hammer home. You talk of 'real world data' yet fail to address the 20 - 70% gap reported in many of today's articles? Why such a wide variation of answers if it's all so straight forward? If in 2 weeks they deem the risk of rising hospitalizations risk to be null, zero, negligible, I'll happily adjust my outlook accordingly. Symptom severity is a red herring - it's a sharp rise hospitalizations after the Christmas mixing that's the ongoing risk.

Docdaneeka,
Because that's NOT what the scientists are saying (not the SAGE scientists and not the ICL researchers that produced this data), as you probably know. The caveats they have put around latest data have been largely ignored in today's many news articles quoting anything from 20 - 70% 'possible' reduction in hospitalisations - laughably vague and guesswork at best? Less severe symptoms do not equal low rise in hospitalisations over a population of millions. Wait for the data - ICL are correct, it's too early to make a call. Or, you can think it's all over much like your prediction last Summer. That was wrong though, wasn't it?

Who is they Doc83. Guardian, sky, dm, ICL? They all quote vastly different % (!) because, as the owners and producers of the data (Imperial college London) said “ The researchers caution that insufficient time has passed for enough data to have accumulated for severity to be judged for more severe outcomes such as intensive care unit admission or death. ”

Trust the science, not the opinions of editors.

Same as it ever was. Fake Honey’s reappearance, along with a few more this afternoon, signals the usual bout of fake worries, woes and waffle. Cue violins.

Aurora is probably a front for HM UK Gov. Stranger things have happened.

If anyone has time to kill (lol), it would be worth registering (it's free) on Webscape and adding some intelligent comments under that article about SNG001, it's merits, how formulation is different to subcutaneous, international P3 trial results 'imminent', etc....

It's a full transcript of their interview, for those who missed it. Plus video.

I meant 'on Medscape' (not webscape).

Just noticed this on Webscape, so it was disseminated more widely than WebMD, which is good.

https://www.medscape.com/viewarticle/964967

Guys, I have regular headaches (migraines, the worst) and fatigue. Can be caused by virtually anything, lack of hydration, low vitamin absorbtion, allergies, etc etc. If you are convinced it's caused by the vaccine / booster, submit a yellow card online, every little bit helps.

Ducati,
This is a very interesting piece, thank you for posting.
I know there is such a test in the US (I don't recall the name but I'll dig out) where your immune response is essentially studied to see if your likely outcome would be severe or not, then take necessary precautions etc with that knowledge. They don't sell it outside of the US, but I'm sure others will follow in time

Brand,
Yes. And I've sent a very direct question about SNG001's adoption here in UK in 2022 to J. Van Tam ahead of the lecture. I expect he can choose which questions to address, but it would be embarrassing for him to sidestep a homegrown talent amongst the Southampton scientific glitterati! I hope he talks of Synairgen, he absolutely must. If others are registering, please ask if it is planned to use Synairgen's inhaled IFB treatment SNG001 in the UK in 2022, pending good P3 international trial results.

If anyone's interested - I think you can register via Eventbrite:

Online lecture on Monday 24 January 2022, 18:00 - 19:00 GMT
Annual Wade Lecture: In conversation with Professor Jonathan Van-Tam and Professor Sir Ian Diamond, the UK’s National Statistician. " In this event we will discuss the future landscape of COVID-19, what the evidence has told us about pandemic preparedness, and the crucial benefits that academic and industry collaboration creates."